Hormone News and Research

RSS

A hormone is a chemical released by one or more cells that affects cells in other parts of the organism. Only a small amount of hormone is required to alter cell metabolism. It is essentially a chemical messenger that transports a signal from one cell to another.

Polycystic ovary syndrome more common than originally thought

Researchers at Cedars-Sinai Medical Center and the University of Alabama, Birmingham, have found that a complex hormonal disorder affecting the reproductive and metabolic function of premenopausal women may be considerably more common in the United States than previously believed from earlier, smaller studies.

5 Jun 2004

Genes that allow nerve cells to communicate may have come from bacteria eons ago

Some of the genes that allow nerve cells and some other types of cells to send elaborate chemical messages to each other appear to have been transferred to animals or their immediate ancestors from bacteria eons ago.

2 Jun 2004

Women with chest pain who have low hemoglobin levels are more likely to die or suffer a heart attack

Women with chest pain who have low hemoglobin levels are more likely to die or suffer a heart attack, heart failure, stroke or other cardiovascular event than women with normal hemoglobin levels, according to a new study in the June 2, 2004 issue of the Journal of the American College of Cardiology.

2 Jun 2004

Yo-yo dieting may have a lasting negative impact on immune function

Yo-yo dieting, in which a person repeatedly loses and regains weight, may have a lasting negative impact on immune function, according to new findings by researchers at Fred Hutchinson Cancer Research Center.

1 Jun 2004

Mothercare, John Lewis and Argos worst stores in UK for dangerous chemicals

High street stores must do more to phase out chemicals which may adversely affect human health, Friends of the Earth said today. The call coincides with a new survey by the environmental campaign group showing some stores are still not taking effective action to remove risky chemicals from their products.

1 Jun 2004

Novel molecular targeting technologies to deliver gene-silencing therapy

Researchers have combined novel molecular targeting technologies to deliver gene-silencing therapy specifically to tumor cells shielded by a normally impermeable obstacle, the blood brain barrier.

1 Jun 2004

Discovery of a key marker in breast cancer tumors

Cancer researchers at Georgetown University Medical Center have discovered a key marker in breast cancer tumors that may help determine which women with early stage breast cancer have a better chance of survival. The research appears in the June 1 issue of the Journal of Clinical Oncology.

31 May 2004

There are still benefits from hormone therapy after menopause

Despite the highly publicized closing of the Women’s Health Initiative study, the scientific community should not rule out that women may benefit from hormone therapy after menopause, say researchers at UC Davis, Duke and Harvard Universities.

31 May 2004

Women who regularly take aspirin at lower risk of breast cancer

Women who regularly take aspirin seem to be at lower risk of the most common type of breast cancer than those who do not take aspirin, report researchers from Columbia University's Mailman School of Public Health and College of Physicians & Surgeons, Weill Cornell Medical College , and New York-Presbyterian Hospital.

31 May 2004

Current test for prostate cancer is inadequate

Britain’s top cancer scientists claim that men’s health is at risk because the current test for prostate cancer is inadequate. The warning comes as The Institute of Cancer Research launches the 7th Everyman Male Cancer Awareness Month to alert men to the risk of prostate and testicular cancer.

27 May 2004

₤16.5 million investment in stem cell research

A ₤16.5 million investment in stem cell research was announced today, 27th May, promising to speed the development of new treatments and cures from the laboratory to the clinic. In total, 57 multidisciplinary research grants have been awarded as part of the new monies allocated via the 2002 Government Spending Review to the UK Research Councils.

27 May 2004

How women would like to manage heavy periods

According to a new online survey of women with heavy periods, women have strong opinions about what they want – and what they don't want to do – to manage their heavy periods.

25 May 2004

Need to determine if black cohosh can improve the quality of people’s lives as some claim

It’s a common herb that more than 10 million American women use to ease menopausal symptoms. Its benefits are touted all over the Internet. Yet, the U.S. Food and Drug Administration has not approved it as a drug, and researchers are unsure of its effects on the human body. A University of Missouri-Columbia researcher is hoping to change that.

25 May 2004

Study indicates the number of people in the UK who could be incubating vCJD

The Journal of Pathology recently published a paper entitled Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. The study looked at 12,674 stored appendix and tonsil samples, and found that 3 of them showed evidence of the prion protein associated with variant Creutzfeldt-Jakob Disease (vCJD).

25 May 2004

Bio-identical hormone replacement therapy (BHRT) - an alternative to hormone replacement therapy (HRT)

Throughout the course of a woman's life she may experience many hormone related symptoms or problems, including premenstrual syndrome, hot flashes, unexplained mood swings, osteoporosis, weight gain and low libido. Many of these symptoms are caused by hormonal imbalances, often from menopause.

25 May 2004

Zengen announces positive results of treatment for vaginal yeast infection

Zengen Inc. announced today positive phase I/II results for its proprietary molecule CZEN-002 for the treatment of vulvovaginal candidiasis (VVC), commonly known as vaginal yeast infection.

25 May 2004

Women who regularly take aspirin seem to be at lower risk of the most common type of breast cancer

Women who regularly take aspirin seem to be at lower risk of the most common type of breast cancer than those who do not take aspirin, report researchers from Columbia University’s Mailman School of Public Health and College of Physicians & Surgeons, Weill Cornell Medical College, and NewYork-Presbyterian Hospital.

25 May 2004

Launch of Zorbtive for use in the treatment of patients with short bowel syndrome

Serono, Inc., the US affiliate of Serono, announced today the launch of Zorbtive™ [somatropin (rDNA origin) for injection] for use in the treatment of patients with short bowel syndrome.

25 May 2004

A new guideline evaluates the treatment of infantile spasms

A new guideline developed by the American Academy of Neurology and the Child Neurology Society evaluates the treatment of infantile spasms. The guideline is published in the May 25 issue of Neurology, the scientific journal of the American Academy of Neurology.

24 May 2004

New series of clinical standards to diagnose heart attacks

Diagnosing heart attacks will become a more precise science thanks to the first of a new series of clinical standards just issued by the National Institute of Standards and Technology (NIST). Standard Reference Material (SRM) 2921 (human cardiac troponin complex) will help manufacturers develop and calibrate assays that measure specific protein concentrations in patient blood samples to determine whether a heart attack has occurred.

24 May 2004